Skip to main content
. 2022 Jun 23;14(7):1326. doi: 10.3390/pharmaceutics14071326

Figure 4.

Figure 4

Percent viability of cancer cells treated with different concentrations of Q or QNPs for 24 h, (A) Human cervical cancer cell line HeLa; (B) MCF-7 breast cancer cell line. * p < 0.05 or ** p < 0.01 or *** p < 0.001 as compared to control.